LABORATORIO FARMAC.ERFO (RK7) — Cash Flow Quality Index
LABORATORIO FARMAC.ERFO (RK7) has a Cash Flow Quality Index of 2.20x as of December 2023. Operating cash flow of €1.30 Million exceeds net income of €590.33K, indicating high earnings quality where cash backs reported profits. Also explore how large is LABORATORIO FARMAC.ERFO's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
LABORATORIO FARMAC.ERFO Cash Flow Quality Index (2021–2023)
Historical Cash Flow Quality Index for LABORATORIO FARMAC.ERFO across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LABORATORIO FARMAC.ERFO tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year earnings quality comparison for LABORATORIO FARMAC.ERFO. For live market cap and the full company financial profile, see RK7 market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.20x | €1.30 Million | €590.33K | ▲ +106.5% |
| 2022 | 1.06x | €761.80K | €716.07K | ▼ -45.8% |
| 2021 | 1.96x | €2.27 Million | €1.16 Million | — |